Gamesys Group PLC Announces ISS ESG Rating and UN Global Compact Signatory
LONDON, UK / ACCESSWIRE / February 2021 / Gamesys Group plc, (OTC PINK:JKPTF) a leading…
LONDON, UK / ACCESSWIRE / February 2021 / Gamesys Group plc, (OTC PINK:JKPTF) a leading…
LONDON, UK / ACCESSWIRE / February 25, 2021 / Gamesys Group plc, (OTC PINK:JKPTF) a…
VANCOUVER, BC / ACCESSWIRE / February 25, 2021 / LINK GLOBAL TECHNOLOGIES INC. (CSE:LNK)(FRA:LGT)(OTC PINK:LGLOF)…
VANCOUVER, BC / ACCESSWIRE / February 25, 2021 / Pampa Metals Corp. (“Pampa Metals” or…
Leading advisory business steps up to support UK corporates LONDON – Exton Advisors, a leading…
UKCloud’s focus and commitment to its ‘Powered By’ programme demonstrates how Technology Providers are key…
Cradlepoint and Panasonic solution in 66 fleet vehicles enables Norfolk Fire & Rescue to send…
Finsit enables accountants to leverage technology to give real-time, data-rich advice 25 February 2021: Kingston,…
Debrichem® offers a very effective, alternative approach to chronic wound care, initiating healing in more…
Positive Phase 2 results with pMDI ensifentrine in COPD Enrollment ongoing in ENHANCE Phase 3…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a collaboration agreement has been signed…
JANUARY – DECEMBER 2020 Net sales amounted to MSEK 0.3 (0.0) Operating expenses amounted to…
February 25, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company…
Excellent progress on clinical programs Unprecedented partnering deal signed with Pfizer for Lyme disease vaccine…
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these…
Initiation of Mechanistic Study of TTP399 expected during Q1 2021 Announcement of First-Patient First-Visit in…
EWING, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE)…
-Broad advancement of clinical pipeline- -Three-arm Phase 2 study of praluzatamab ravtansine (CX-2009) launched in…
– Data demonstrate that ImmTOR has the potential to enhance transgene expression in the liver…